Oppenheimer Starts Relay Therapeutics (RLAY) at Outperform, 'Riding a New Wave of Drug Discovery'
Tweet Send to a Friend
(Updated - February 2, 2023 4:27 PM EST)
Oppenheimer analyst Matt Biegler initiates coverage on Relay Therapeutics (NASDAQ: RLAY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Matt Biegler initiates coverage on Relay Therapeutics (NASDAQ: RLAY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
